Pharmafile Logo
Pharmafocus logo
Advanced Search

niaid

Showing 3 posts of 3 posts found.

trial

NIAID announces the launch of second remdesivir trial for COVID-19 patients

May 11, 2020
Sales and Marketing COVID-19, coronavirus, niaid, remdesivier

The US National Institute of Allergy and Infectious Diseases (NAID) has announced that it is enrolling COVID-19 patients in hospital …

News
14712294170_aaaf8f499d_z

Ebola drugs prove 90% effective in clinical trial in DRC

August 13, 2019
Manufacturing and Production, Research and Development Congo, DRC, Ebola, clinical trials, infectious diseases, niaid, pharma

Health professionals in the Democratic Republic of Congo (DRC) are now offering two experimental drugs to people infected with Ebola, …

News
J&J image

J&J announces ‘major commitment’ to Ebola effort

October 22, 2014
Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid

Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024